Perdue has been lying to Georgians all year about not having “discretion over which trades were made and when” in his active stock portfolio
ATLANTA — New details uncovered by Salon revealed that around the time of Senator David Perdue’s buyback of Cardlytics stock, the company on whose board Perdue once sat “quietly rolled out a “COVID-19 Dashboard” to help its clients track and target consumer spending during the pandemic,” as its executives later argued that the pandemic was “playing in our favor” and that the company was “probably in its best position ever and really well positioned to grow.”
On the earnings call, a Cardlytics executive assured that pandemic-induced trends were “very much in the favor of our platform,” adding to already intense federal scrutiny concerning Perdue’s stock trades amid the coronavirus pandemic and what information he knew before his previous stock trading scandals.
After receiving a personal email from the Cardlytics CEO mentioning “upcoming changes” in January, Perdue sold more than $1 million worth of Cardlytics shares before the company’s stock plummeted, avoiding “a sharp loss” and “reap[ing] a stunning gain” by selling and then buying the same stock.
“Perdue has been lying to Georgians all year about his stock trades, and the more details we find out, the clearer it is that Perdue worked to line his pockets,” said Braxton Brewington, spokesman for the Democratic Party of Georgia. “There is no way voters can trust Perdue since he’s clearly out for himself, which is why he won’t be getting reelected to another term in Washington.”